Latest in Drug Delivery

Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma

The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic blood-brain barrier transporter approaches. The results also suggest strong support for therapeutically relevant clinical effects of semaglutide using MetP Pharma’s DDT

Find out more

You need to be a subscriber to read this article.
Click here to find out more.

Strong data foundations determine success in AI/ML

AI and machine learning are increasingly embedded across the chemical R&D lifecycle, from discovery to QA/QC, with their greatest value emerging when high-quality, standardised...
See more

Indonesia looks to oral GLP-1s as it battles rising obesity

Novo Nordisk's oral GLP-1 therapy for chronic weight management could help the country deliver injectable-comparable weight loss alongside cardiovascular risk-reduction benefits for its expanding population

MetP Pharma unveils brain-targeted intranasal GLP-1 delivery technology

Preclinical data shows the company's proprietary nose-to-brain technology enables rapid, dose-dependent brain targeting of intranasal semaglutide with low systemic exposure, opening new opportunities for CNS-focused GLP-1 therapies

SCHOTT Pharma and SHL Medical pre-validate polymer cartridge platform for large-volume autoinjectors

SCHOTT Pharma has pre-validated its ISO-standardised TOPPAC polymer cartridge for compatibility with SHL Medical’s large-volume Maggie autoinjector platform. The collaboration delivers a de-risked, ready-to-use solution for the safe at-home administration of large-volume therapies

Bio-Sourcing and Zerion Pharma secure Eurostars funding to develop HER2 oral monoclonal antibody

The pair have been awarded a €1.3m Eurostars grant to develop an oral formulation of the anti-HER2 monoclonal antibody trastuzumab for breast cancer, combining Bio-Sourcing’s BioMilk platform with Zerion’s Dispersome technology to advance the candidate through preclinical development

Zephyrus Innovations receives 510(k) clearance from FDA for VaporShield CSTD

With CSTDs now required in the US under USP<800> legislation, VaporShield is the first direct injection CSTD for subcutaneous and intramuscular administration

Owen Mumford launches EcoSafe safety syringe platform

Medical device expert Owen Mumford has extended its 1 mL safety syringe platform by adding a companion reusable autoinjector.

UT Austin honours AustinPx for breakthrough drug delivery innovation

Fourth industry accolade in the past year recognises breakthrough KinetiSol Technology for advancing pharmaceutical research and innovation

Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies

Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency

Latest posts in Drug Delivery

Spiky magnetic nanorobots pierce tumour defences to boost chemotherapy

In lab and animal studies, the “microscopic scalpels” enhanced drug delivery, reduced tumour growth and extended survival, offering a potential new weapon against drug-resistant cancers

Nuvec nanoparticles successfully target lung cancer cells

N4 Pharma announces further details of its collaboration with SRI International to investigate the targeted delivery of RNA into cells using Nuvec

New TXA autoinjector could save lives in severe bleeding emergencies

In a breakthrough for emergency and trauma medicine, new study results show that TXA autoinjectors deliver lifesaving treatment for severe bleeding in under five minutes and without the need for medical expertise

Tiziana receives grant for intranasal anti-CD3 monoclonal antibody therapy for spinal cord injury

The US Department of Defense awarded the biotechnology company a research grant to study the use of intranasal anti-CD3 therapy in traumatic spinal cord injury (SCI)

Rice University scientists create hydrogel platform for precision, long-lasting drug delivery

The researchers have developed a peptide hydrogel system that slows and extends drug release, improving treatment adherence and efficacy across therapies ranging from tuberculosis medication to insulin

Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS

The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target

Intranasal GLP-1 medication from Orexo shows positive results in preclinical trial

Orexo's AmorphOX technology had positive results when compared against oral and injectable formulations in the study

Drug delivery evolution: pharma breakthroughs drive nasal spray market towards $59.4bn

Dr Steve Ward-Smith at Malvern Panalytical shares how advanced particle analysis is fuelling rapid growth in the nasal spray market
You need to be a subscriber to read this article.
Click here to find out more.

Autoinjector platforms: optimising device selection and unlocking manufacturing efficiency for injectable pipelines

Owing to ageing populations, the increased prevalence of chronic disease and additional pressure on global healthcare systems, among other factors, the market for drug delivery devices for self-administration (autoinjectors) is growing

Breaking barriers: enhancing the bioavailability of orally delivered TPDs

It’s been said that nothing vast enters the realm of mortals without a curse. Such is the case with targeted protein degraders (TPDs), now one of the fastest-growing frontiers in oral solid dose pharmaceuticals

BioMed X and Novo Nordisk launch new collaboration in oral peptide drug delivery

The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists via BioMed X’s global talent sourcing and incubation model

Sponsor content

How are biotech companies using microspheres to go beyond oncology?

Biotech companies are increasingly using microsphere drug delivery technology to expand advanced therapies beyond traditional cancer treatments. In oncology, microspheres...

Piramal Pharma Solutions introduces tablet-in-capsule capabilities

Enhancing dosing flexibility and patient-centric drug delivery

Biosero launches GoSimple™, a standardised automation-ready workcell

GoSimple workcells simplify workflows and enhance lab efficiency with selected Sartorius and BD instruments

SÜDPACK Medica showcases recyclable blister and medical packaging innovations at PharmaPack 2026

From recyclable PP blisters to cleanroom-manufactured pouch solutions, SÜDPACK Medica highlights sustainability and performance in pharma packaging

Inside the shift toward greener, faster, Smarter drug manufacturing

Dave Henderson, Ph.D, MBA, Head of R&D Labs at Asymchem explores the pharmaceutical manufacturing landscape and the challenges CDMOs must address to remain competitive in...

Vetter reaches key launch milestones for the V-OVS next tamper-evident syringe closure system

Several recent steps move the closure toward commercialisation

Gerresheimer at Pharmapack 2026: Innovative solutions for biopharmaceuticals and adherence support

Located in Hall 4, Booth #4G36 it will focus on specialised solutions for sensitive biopharmaceuticals

Cellistic launches new iPSC-based GMP platforms to boost cell therapy development

Echo-T, Echo-Cardio, and Echo-Endothelial enable scalable immuno-oncology and regenerative therapies

IWK introduces machine to produce 100% cardboard blister packaging

CABLIblue 870 features innovative “card-to-card” technology for recyclable, fiber-based blisters

Updated MHRA GMP certificates strengthen Piramal’s bioconjugates capabilities at Grangemouth

Certification renewal supports clinical and commercial ADC development and manufacturing

Science based targets initiative confirms CO2e reduction targets

Targets align with the Paris Agreement to limit global warming to 1.5 °C. Reduction of Scope 1 and 2 emissions by 52% by 2030 and reduction of the intensity of selected...

Breaking down silos and building in seamless scale

A Q&A with Kindeva's Tommy Schornak on the Bridgeton facility, Annex 1 compliance and scaling sterile injectable production

Featured companies

For over 35 years, Powder Systems Limited’s solid liquid processing expertise has been fundamental to our success in providing innovative filtration, drying and microsphere... Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small-molecule and peptide drug... Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries CARBOGEN AMCIS is a global Contract Development and Manufacturing Organization (CDMO) providing drug development and commercialization services to the pharmaceutical and...
See more